RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Jeffrey Tyner(Washington University in St. Louis), Brian Druker(Howard Hughes Medical Institute)
Cited by 69
Related Papers
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
|New England Journal of Medicine|2002|2k
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals
|Journal of Clinical Investigation|2006|260
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML
|Blood|2004|198
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
|Nature Communications|2019|150
Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
|Leukemia|2011|50